![]() Lobesity Lobesity (also known as Lobesity Investors) is a company engaged in the clinical and commercial development of therapies to treat obesity and related disorders. | ![]() Diasome Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity. | ![]() Larimar Therapeutics Larimar Therapeutics (formerly known as Zafgen) is a biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity and complex metabolic disorders. | ![]() Viking Therapeutics Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders. | Metabrain Research Metabrain Research is a company that focuses on drug discovery specializing in metabolic disorders. | |
Founding Date | Founding Date 2015 | Founding Date 2004 | Founding Date 2005 | Founding Date 2012 | Founding Date 2009 |
Type | Type Private | Type Private | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Cleveland, US HQ | Locations Cleveland, US HQ | Locations Bala Cynwyd, US HQ | Locations San Diego, US HQ | Locations Maisons-Alfort, FR HQ |
Employees | Employees 1 | Employees 1515% increase | Employees 782% decrease | Employees 2729% increase | Employees 4 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 496.4 m | Valuation ($) 8.2 b | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income N/A | Net income ($165.7m) (FY, 2025) | Net income ($359.6m) (FY, 2025) | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round $ 722.5k (almost 11 years ago) | Latest funding round $ 30m (almost 9 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 722.5k | Total funding raised $ 42.9m | Total funding raised $ 132.2m | Total funding raised $ 15m | Total funding raised N/A |

Diasome Pharmaceuticals, Inc. is focused on the clinical and commercial development of breakthrough therapies for diabetes and obesity.
View company
Larimar Therapeutics (formerly known as Zafgen) is a biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity and complex metabolic disorders.
View company
Viking Therapeutics is a clinical-stage biotherapeutics company focused on the development of therapies for metabolic and endocrine disorders.
View companyMetabrain Research is a company that focuses on drug discovery specializing in metabolic disorders.
View company